Tina Ventura
Investor Relations Contact chez MADRIGAL PHARMACEUTICALS, INC.
Postes actifs de Tina Ventura
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Investor Relations Contact | 29/01/2024 | - |
| Lake Forest Open Lands Association | Director/Board Member | - | - |
| Lake Forest Country Day School | Director/Board Member | - | - |
Historique de carrière de Tina Ventura
Anciens postes connus de Tina Ventura
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Contact | 01/11/2016 | - |
Formation de Tina Ventura
| Northwestern University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
| Irlande | 2 |
Opérationnelle
| Investor Relations Contact | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| Lake Forest Open Lands Association |
- Bourse
- Insiders
- Tina Ventura
- Expérience
